Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
LB Pharmaceuticals Inc named Susan G. Kozauer, M.D. as Chief Medical Officer. The company highlighted her late-stage neuropsychiatric drug development experience ahead of its Phase 3 NOVA-2 schizophrenia readout expected in H1 2027.Material DetailsContext by AI AnalystThis is an early-to-mid cycle…
NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) NASDAQ:LBRX, a neuromedicines company dedicated to developing and commercializing high-impact therapies that address the multiple dimensions of underserved brain disorders, today announced th…
LBRX - LB Pharmaceuticals Appoints Susan G. Kozauer, M.D. as Chief Medical Officer